科研之友
微信
新浪微博
Facebook
分享链接
摘要
The incidence of osteoporosis induced by glucocorticoid treatment is second only to that owing to oestrogen deficiency. Treatment and prevention of glucocorticoid-induced osteoporosis are, however, problematic. Can a new framework for the development of national guidelines help steer the diagnosis and management of glucocorticoid-induced osteoporosis towards calmer seas?
- 出版日期2012-8
